These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 25559296

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Changes in neurocognitive functioning during transition to manifest disease: comparison of individuals at risk for schizophrenic and bipolar affective psychoses.
    Metzler S, Dvorsky D, Wyss C, Müller M, Gerstenberg M, Traber-Walker N, Walitza S, Theodoridou A, Rössler W, Heekeren K.
    Psychol Med; 2015 Jul; 45(10):2123-34. PubMed ID: 25640248
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Relation between cigarette smoking and cognitive function in euthymic individuals with bipolar disorder.
    Law CW, Soczynska JK, Woldeyohannes HO, Miranda A, Brooks JO, McIntyre RS.
    Pharmacol Biochem Behav; 2009 Mar; 92(1):12-6. PubMed ID: 18976682
    [Abstract] [Full Text] [Related]

  • 27. Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up.
    Lewandowski KE, Cohen BM, Keshavan MS, Sperry SH, Ongür D.
    Schizophr Res; 2013 Aug; 148(1-3):34-7. PubMed ID: 23791391
    [Abstract] [Full Text] [Related]

  • 28. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.
    Depp CA, Moore DJ, Sitzer D, Palmer BW, Eyler LT, Roesch S, Lebowitz BD, Jeste DV.
    J Affect Disord; 2007 Aug; 101(1-3):201-9. PubMed ID: 17224185
    [Abstract] [Full Text] [Related]

  • 29. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N, Arts B, Krabbendam L, van Os J.
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [Abstract] [Full Text] [Related]

  • 30. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S, Dias VV, Carita AI, Martinez-Arán A.
    Psychiatry Res; 2008 Jul 15; 160(1):55-62. PubMed ID: 18485488
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders.
    Diwan A, Castine M, Pomerleau CS, Meador-Woodruff JH, Dalack GW.
    Schizophr Res; 1998 Sep 07; 33(1-2):113-8. PubMed ID: 9783351
    [Abstract] [Full Text] [Related]

  • 33. Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls.
    AhnAllen CG, Bidwell LC, Tidey JW.
    Nicotine Tob Res; 2015 May 07; 17(5):510-4. PubMed ID: 25143294
    [Abstract] [Full Text] [Related]

  • 34. Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia.
    Jiménez-López E, Sánchez-Morla EM, Aparicio AI, López-Villarreal A, Martínez-Vizcaíno V, Rodriguez-Jimenez R, Vieta E, Santos JL.
    J Affect Disord; 2018 Mar 15; 229():177-185. PubMed ID: 29316520
    [Abstract] [Full Text] [Related]

  • 35. Premorbid tobacco smoking is associated with later age at onset in schizophrenia.
    Ma X, Li C, Meng H, Du L, Wang Q, Wang Y, Deng W, Liu X, Hu X, Murray RM, Collier DA, Li T.
    Psychiatry Res; 2010 Aug 15; 178(3):461-6. PubMed ID: 20493556
    [Abstract] [Full Text] [Related]

  • 36. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J.
    Biol Psychiatry; 2004 Oct 15; 56(8):560-9. PubMed ID: 15476685
    [Abstract] [Full Text] [Related]

  • 37. Neurocognitive functioning during symptomatic states and remission in bipolar disorder and schizophrenia: A comparative study.
    Ceylan D, Akdede BB, Bora E, Aktener AY, Hıdıroğlu Ongun C, Tunca Z, Alptekin K, Özerdem A.
    Psychiatry Res; 2020 Oct 15; 292():113292. PubMed ID: 32707217
    [Abstract] [Full Text] [Related]

  • 38. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
    Evins AE, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, Achtyes ED, Ayer D, Schoenfeld DA.
    JAMA; 2014 Jan 08; 311(2):145-54. PubMed ID: 24399553
    [Abstract] [Full Text] [Related]

  • 39. Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome.
    Martínez-Arán A, Penadés R, Vieta E, Colom F, Reinares M, Benabarre A, Salamero M, Gastó C.
    Psychother Psychosom; 2002 Jan 08; 71(1):39-46. PubMed ID: 11740167
    [Abstract] [Full Text] [Related]

  • 40. Comparison of social functioning in community-living older individuals with schizophrenia and bipolar disorder: a catchment area-based study.
    van Liempt S, Dols A, Schouws S, Stek ML, Meesters PD.
    Int J Geriatr Psychiatry; 2017 May 08; 32(5):532-538. PubMed ID: 27121916
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.